[Mindray Medical Announces Top Management Change SHENZHEN, China, November 5, 2012 /PRNewswire-FirstCall/ — Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that Mr. Xu Hang, has resigned from his co-chief executive officer (co-CEO) position, effective immediately, but will continue to serve as Mindray’s chairman. Mr. Li Xiting, Mindray’s president and]

[Mindray Announces Third Quarter 2012 Financial Results Shenzhen, China – November 5, 2012 – Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September 30, 2012. Highlights for Third Quarter 2012 • Net revenues were $257.1 million, up 17.7% over the]

[Mindray Medical Announces Top Management Change STYLE="font-family:Times New Roman" SIZE="2"> SHENZHEN, China,November 5, 2012/PRNewswire-FirstCall/ Mindray Medical International Limited(NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that Mr. Xu Hang, has resigned from his-chief executive officer (co-CEO) position, effective immediately, but willntinue to serve Mindrays chairman. Mr.Li Xiting, Mindrays president]

[Mindray Announces Third Quarter 2012 Financial Results STYLE="font-family:Times New Roman" SIZE="2"> Shenzhen, China November5, 2012 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September30, 2012. Highlights for Third Quarter 2012 Net revenues were $257.1 million,]

[Mindray Medical Announces Top Management Change SHENZHEN, China,November 5, 2012/PRNewswire-FirstCall/ Mindray Medical International Limited(NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that Mr. Xu Hang, has resigned from his-chief executive officer (co-CEO) position, effective immediately, but willntinue to serve Mindrays chairman. Mr.Li Xiting, Mindrays president and-CEO, has been appointed]

[Mindray Announces Third Quarter 2012 Financial Results Shenzhen, China November5, 2012 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September30, 2012. Highlights for Third Quarter 2012 Net revenues were $257.1 million, up 17.7% over the]